Mon. 13 May 2024, 4:02pm ET
Benzinga
Earnings, Earnings Beats, News
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.45) by 55.56 percent. This is a 106.8 percent decrease over earnings of $2.94 per share from the same period last year. The company reported quarterly sales of $19.516 million which beat the analyst consensus estimate of $9.415 million by 107.29 percent. This is a 87.03 percent decrease over sales of $150.480 million the same period last year.